These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31465633)

  • 21. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
    Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H
    Malar J; 2015 Aug; 14():325. PubMed ID: 26289949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple dose regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefantrine.
    Gbotosho GO; Sowunmi A; Okuboyejo TM; Happi CT; Folarin OO; Adewoye EO
    Am J Ther; 2012 Jul; 19(4):e122-31. PubMed ID: 21519221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar.
    Ratsimbasoa A; Ravony H; Vonimpaisomihanta JA; Raherinjafy R; Jahevitra M; Rapelanoro R; Rakotomanga Jde D; Malvy D; Millet P; Ménard D
    Am J Trop Med Hyg; 2012 Feb; 86(2):203-10. PubMed ID: 22302849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo.
    de Wit M; Funk AL; Moussally K; Nkuba DA; Siddiqui R; Bil K; Piriou E; Bart A; Bahizi Bizoza P; Bousema T
    Malar J; 2016 Sep; 15(1):455. PubMed ID: 27599612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana.
    Abuaku BK; Mensah BA; Ofori MF; Myers-Hansen J; Derkyi-Kwarteng AN; Essilfie F; Dokurugu M; Amoakoh E; Koram KA; Ghansah A
    Am J Trop Med Hyg; 2017 Sep; 97(3):690-695. PubMed ID: 28749762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
    Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
    PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social group and health-care provider interventions to increase the demand for malaria rapid diagnostic tests among community members in Ebonyi state, Nigeria: a cluster-randomised controlled trial.
    Omale UI; Azuogu BN; Alo C; Madubueze UC; Oka OU; Okeke KC; Okafor IM; Utulu R; Eze II; Akpan UE; Iloke CV; Nnubia AO; Anene OC; Nnabu CR; Ibemesi DO
    Lancet Glob Health; 2021 Mar; 9(3):e320-e330. PubMed ID: 33607030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction.
    Gerstl S; Cohuet S; Edoh K; Brasher C; Lesage A; Guthmann JP; Checchi F
    Malar J; 2007 Jul; 6():94. PubMed ID: 17640357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demand for malaria rapid diagnostic test, health care-seeking behaviour, and drug use among rural community members with fever or malaria-like illness in Ebonyi state, Nigeria: a cross-sectional household survey.
    Omale UI; Oka OU; Okeke IM; Azuogu BN; Alo C; Madubueze UC; Eze II; Okeke KC; Utulu R; Akpan UE; Iloke CV; Nnubia AO; Ibemesi DO; Nnabu CR; Anene OC
    BMC Health Serv Res; 2021 Aug; 21(1):857. PubMed ID: 34419029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of malaria rapid diagnostic test and anti-malarial drug prescription practices among primary healthcare workers in Ebonyi state, Nigeria: An analytical cross-sectional study.
    Omale UI; Azuogu BN; Agu AP; Ossai EN
    PLoS One; 2024; 19(6):e0304600. PubMed ID: 38833491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved diagnostic testing and malaria treatment practices in Zambia.
    Hamer DH; Ndhlovu M; Zurovac D; Fox M; Yeboah-Antwi K; Chanda P; Sipilinyambe N; Simon JL; Snow RW
    JAMA; 2007 May; 297(20):2227-31. PubMed ID: 17519412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failures in the case management of children with uncomplicated malaria in Bata district of Equatorial Guinea and associated factors.
    Suárez-Sánchez P; García B; Nzang J; Ncogo P; Riloha M; Berzosa P; Benito A; Romay-Barja M
    PLoS One; 2019; 14(8):e0220789. PubMed ID: 31374107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.
    Ndounga M; Pembe Issamou Mayengue ; Casimiro PN; Koukouikila-Koussounda F; Bitemo M; Diassivy Matondo B; Ndounga Diakou LA; Basco LK; Ntoumi F
    Malar J; 2015 Oct; 14():423. PubMed ID: 26511848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of uncomplicated malaria among children under five years at public and private sector facilities in Mali.
    Fomba S; Koné D; Doumbia B; Diallo D; Druetz T; Florey L; Eisele TP; Eckert E; Mihigo J; Ashton RA
    BMC Public Health; 2020 Dec; 20(1):1888. PubMed ID: 33298011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria rapid diagnostic tests for the case management of febrile children in Nigerian primary healthcare settings: a cross-sectional study.
    Ali PO; Okebe J; Oduwole OA
    J Egypt Public Health Assoc; 2022 May; 97(1):10. PubMed ID: 35551536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could combined rapid diagnostic testing for malaria and c-reactive protein be helpful for the diagnosis and management of febrile illnesses in children under-5 years of age in rural Burkina Faso?
    Bonko MDA; Karama I; Kiemde F; Lompo P; Garba Z; Yougbaré S; Mens PF; Tinto H; Tahita MC; Schallig HDFH
    BMC Infect Dis; 2022 Dec; 22(1):952. PubMed ID: 36536340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT.
    Willcox ML; Graz B; Diakite C; Falquet J; Dackouo F; Sidibe O; Giani S; Diallo D
    Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):23-31. PubMed ID: 21056445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.